Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Briacell Therapeutics Corp WT (NQ: BCTXW ) 0.3590 UNCHANGED Streaming Delayed Price Updated: 3:53 PM EDT, Oct 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.3590 Bid (Size) 0.1400 (20) Ask (Size) 0.5170 (1) Prev. Close 0.3590 Today's Range 0.3590 - 0.3590 52wk Range 0.1055 - 2.600 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers January 18, 2023 From my analysis of BriaCell, it would make a great buy and hold investment. If, and when, it is bought out by a major pharmaceutical company, or brings a product directly to market itself, its stock... Via Talk Markets BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer January 18, 2023 Registration study success could lead to a Biologics License Application (BLA) submission and commercialization approvals for BriaCell’s novel immunotherapy approach. Via Talk Markets Performance YTD -85.04% -85.04% 1 Month +89.35% +89.35% 3 Month +156.43% +156.43% 6 Month -67.95% -67.95% 1 Year -79.49% -79.49% More News Read More BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients December 14, 2022 Via News Direct Topics Death Exposures Death BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients December 14, 2022 Via TheNewswire.com Topics Death Exposures Death BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients December 13, 2022 Via Benzinga BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients December 01, 2022 Via Benzinga IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies November 30, 2022 From ImmunoPrecise Antibodies Via Business Wire Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021 August 16, 2021 From Stock News Now Via AccessWire Topics Cannabis Exposures Cannabis Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
